The goal of the Children’s Health & Discovery initiative (CHDI) is to foster multidisciplinary and innovative research that will positively impact childhood and lifelong health. Efforts in four key research focus areas (genes and biology, physical environment, social and economic factors, and health and behavior needs) will inform prevention, risk screening, and treatment, as well as provide training opportunities for the next generation of pediatrician-scientists to learn from Duke’s cadre of experts. As part of our goal of fostering multidisciplinary collaborations, the CHDI is holding seminar/brainstorming sessions, which we’ve termed “Great Minds Think for Kids”, beginning this January. These sessions will include a 40-minute research-in-progress talk from a guest speaker, followed by a 40-minute brainstorming/group discussion session led by the guest speaker and a member of the CHDI scientific leadership.
Details about the December seminar/brainstorming session follow:
Date: December 7, 2021
Time: 12:00 to 1:00 pm
Join Zoom Meeting
Meeting ID: 857 4449 5636
One tap mobile
+19294362866,,85744495636#,,,,*959585# US (New York)
+13017158592,,85744495636#,,,,*959585# US (Washington DC)
Dial by your location
+1 929 436 2866 US (New York)
+1 301 715 8592 US (Washington DC)
+1 312 626 6799 US (Chicago)
+1 669 900 6833 US (San Jose)
+1 253 215 8782 US (Tacoma)
+1 346 248 7799 US (Houston)
Meeting ID: 857 4449 5636
Find your local number: https://us02web.zoom.us/u/kb3PlUG0jd
Seminar Title: "Conventional and Adaptive NK Cell Responses to Viral Infections"
Speaker: R. Keith Reeves, PhD
Professor in Surgery
Division of Surgical Sciences
Director of the Division of Innate and Comparative Immunology
Head of Innovation Partnerships for the Center for Human Systems Immunology
Dr. Reeves received his PhD from the University of Alabama-Birmingham in 2007. His postdoctoral work at Harvard Medical School and the New England Primate Research Center (NEPRC) began on attenuated lentivirus vaccines, but later transitioned to studies on natural killer (NK) cell biology and innate lymphoid cells in human immunodeficiency virus (HIV) and simian immunodeficiency virus (SIV) infections. Dr. Reeves started his own lab at NEPRC and, later, the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, where prior to his move to Duke he was Associate Professor of Medicine and Director of Advanced Technologies for the Harvard Center for AIDS Research.
If you have questions or need additional information, please contact Jillian Hurst at email@example.com or 919.668.8776.